Profile of brentuximab vedotin and its potential in the treatment of relapsed or refractory Hodgkin lymphoma

Overview of attention for article published in Blood and Lymphatic Cancer: Targets and Therapy, May 2012

Altmetric Badge

About this Attention Score

So far, Altmetric has seen 2 X posts from 2 X users, with an upper bound of 8,269 followers.

Profile of brentuximab vedotin and its potential in the treatment of relapsed or... http://t.co/LxSHtMhw

Brentuximab vedotin in Hodgkin lymphoma http://t.co/qNgtj3Gt #dovepress

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.